Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET

Rhea-AI Summary

Fulcrum Therapeutics (Nasdaq: FULC) will release its first quarter 2026 financial results on Monday, April 27, 2026, before U.S. markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss results and recent corporate developments.

Investors may register to receive dial-in details and a unique PIN; an audio webcast and archived replay will be available via the Investor Relations site at www.fulcrumtx.com.

News Market Reaction – FULC

-4.22%

4 alerts

-4.22% Session close to close

-11.0% Trough Tracked

$552.12M Market Cap

0.2x Rel. Volume

In the Apr 20 session, FULC declined 4.22%, reflecting a moderate negative market reaction. Argus tracked a trough of -11.0% from its starting point during tracking. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the timetable for Fulcrum’s first quarter 2026 financial results release and ...

Analysis

This announcement sets the timetable for Fulcrum’s first quarter 2026 financial results release and accompanying 8:00 a.m. ET conference call. It follows a well-established pattern of pre-announcing quarterly calls, as seen across multiple prior "conferences,earnings" notices. Investors will likely focus on how upcoming results and commentary relate to prior disclosures on cash levels, ongoing clinical development, and the broader strategy for genetically defined rare diseases.

Key Figures

Results date: April 27, 2026 Call time: 8:00 a.m. ET

2 metrics

Results date April 27, 2026 First quarter 2026 financial results release before U.S. markets open

Call time 8:00 a.m. ET Scheduled start time for Q1 2026 conference call and webcast

Previous Conferences,earnings Reports

5 past events · Latest: Oct 22 (Neutral)

Same Type Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Oct 22	Earnings call notice	Neutral	-6.8%	Scheduled Q3 2025 results release and 8:00 a.m. ET conference call.
Apr 24	Earnings call notice	Neutral	-2.2%	Announced Q1 2025 results date and related conference call/webcast.
Feb 18	Earnings call notice	Neutral	+1.9%	Set Q4 and full-year 2024 results timing and investor call details.
Nov 06	Earnings call notice	Neutral	+3.3%	Outlined Q3 2024 results release and corporate update webcast.
Jul 24	Earnings call notice	Neutral	-3.2%	Announced Q2 2024 results date and 8:00 a.m. ET conference call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Similar "results call" scheduling headlines have usually led to small moves, averaging a -1.41% change over the last five such events.

Recent Company History

Over the past several quarters, Fulcrum has routinely pre-announced its earnings release and conference call schedule, typically about a week before results. Past "conferences,earnings" notices on Jul 31, 2024, Nov 13, 2024, Feb 25, 2025, May 1, 2025, and Oct 29, 2025 produced modest mixed reactions, with single‑day moves ranging from roughly low single‑digit declines to a 3.31% gain. Today’s announcement continues that established communication pattern ahead of quarterly results.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.^® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that its first quarter 2026 financial results will be released on Monday, April 27, 2026, before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments.

Individuals may register for the conference call by clicking the link here. Once registered, participants will receive dial-in details and unique PIN which will allow them to access the call. An audio webcast will be accessible through the Investor Relations section of the company’s website at www.fulcrumtx.com or by clicking here. Following the live webcast, an archived replay will also be available.

About Fulcrum Therapeutics
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on the development of small molecule therapies that improve the lives of people with rare hematological disorders. The company’s lead clinical program is pociredir, a small molecule designed to increase expression of fetal hemoglobin (HbF) for the treatment of sickle cell disease (SCD). Fulcrum uses proprietary technology to identify drug targets that can modulate gene expression to treat the known root cause of genetically defined diseases. For more information, visit www.fulcrumtx.com and follow us on X (@FulcrumTx) and LinkedIn.  

Contact:
Kevin Gardner
LifeSci Advisors, LLC
kgardner@lifesciadvisors.com
617-283-2856

FAQ

When will Fulcrum Therapeutics (FULC) release Q1 2026 financial results?

Fulcrum will release Q1 2026 results on Monday, April 27, 2026, before U.S. markets open. According to the company, management will discuss those results during a conference call and webcast scheduled for 8:00 a.m. ET, offering an investor update on corporate developments.

How can investors join Fulcrum's April 27, 2026 conference call for FULC?

Investors can join by registering in advance to receive dial-in details and a unique PIN. According to the company, registration provides the call dial-in, a PIN for access, and instructions to participate in the live conference call and webcast.

Where will the FULC webcast and replay be available after the April 27, 2026 call?

The live audio webcast and archived replay will be available on Fulcrum's Investor Relations website at www.fulcrumtx.com. According to the company, the replay will remain accessible after the live event for investors who cannot attend the live webcast.

What topics will Fulcrum management cover on the April 27, 2026 FULC call?

Management will discuss first quarter 2026 financial results and recent corporate developments. According to the company, the call and webcast are intended to review the quarter's results and provide updates on clinical and corporate progress relevant to investors.

Is a unique PIN required to access Fulcrum's FULC conference call on April 27, 2026?

Yes, a unique PIN is required to access the conference call after registration. According to the company, once registered participants will receive dial-in details and a unique PIN which will allow them to access the live call.

What time is Fulcrum's (FULC) April 27, 2026 earnings call and does it occur before market open?

The call is scheduled for 8:00 a.m. ET on April 27, 2026, and the results will be released before U.S. markets open. According to the company, the timing is set to provide results and a management update ahead of market open.